1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
65F479D188A200E0C65258305002213E0
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-digital-patient-engagement-strategies-global-emerging-developed-markets-structure-technology-tools-successful-programs?opendocument
18
19opendocument
2018.205.176.100
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Patient Advocacy

Digital Patient Engagement Strategies in Global, Emerging, and Developed Markets: Structure, Technology and Tools for Successful Engagement Programs

ID: 5522


Features:

5 Info Graphics

20 Data Graphics

380+ Metrics

3 Narratives


Pages/Slides: 35


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Digital Patient Engagement Strategies in Global, Emerging, and Developed Markets: Structure, Technology and Tools for Successful Engagement Programs”

STUDY OVERVIEW



With the emergence of novel tools and technologies in the healthcare industry, leading pharmaceutical, biotechnology and medical device organizations are making a shift toward digital patient engagement in global, emerging and developed markets.

However, to attain higher levels of digital patient engagement in each of these markets, it is important to optimize the structure and reporting levels of Digital Patient Engagement groups. Also, it is critical to adopt the latest tools and technologies to stay ahead of the curve.

Best Practices, LLC undertook this benchmarking research to uncover the winning strategies and tactics employed by leading life sciences organizations as they shift toward digital patient engagement in global, emerging and developed markets. In particular, this study delivers benchmarks around the technologies, tools, structure and reporting levels required for deploying successful digital patient engagement programs in each of these markets.

Insights in this benchmarking study are presented into three segments: Global Market Segment, Developed Market Segment and Emerging Market Segment.

KEY TOPICS

  • Effective digital tactics and technologies
  • Effective patient feedback tools
  • Access to health records
  • Frequency of outreach to patients and HCPs
  • Digital patient engagement reporting authority
  • Effective knowledge transfer channels

KEY METRICS

  • Which of the listed digital tactics or technologies do you employ in your Digital Patient Engagement programs?
  • How would you rate the effectiveness of the activities you utilize as part of your organization’s Digital Patient Engagement program?
  • How effective have the listed patient feedback collection tools been for segmenting patients to receive engagement messages aligned with different phases of their journey?
  • Which of the mentioned statements best describes your patient engagement group’s involvement with Patient Health Records in emerging markets?
  • Please indicate the outreach frequencies to HCPs and patients through external engagement programs
  • What is the reporting structure of those responsible for Digital Patient Engagement programs?
  • Please indicate the effectiveness of each channel through which you internally exchange knowledge, breakthroughs, and innovations with your colleagues for Digital Patient Engagement programs

SAMPLE KEY FINDINGS

  • Preferred Tools: Program-branded websites and newsletters are highly employed in Global markets, while website portals and SMS reminders are employed the most by companies in Emerging markets. Companies in Developed markets employ unbranded educational documents the most. Consequently, programs established in Emerging markets see a higher level of engagement than those in Global or Developed markets. This can be attributed to the straightforward, accessible nature of digital engagement programs in Emerging markets.

METHODOLOGY

Best Practices, LLC engaged 54 industry professionals involved in digital patient engagement programs at 34 leading pharmaceutical, biotechnology and medical device companies through a benchmarking survey.


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Manufacturing; Consumer Products; Medical Device; Chemical; Biopharmaceutical; Research; Clinical Research; Laboratories


Companies Profiled:
Abbott; AbbVie; Alexion Pharmaceuticals; Allergan; Astellas; AstraZeneca; Bayer; B. Braun; Cadila Pharmaceuticals; Cordis; Ferring Pharmaceuticals; Fidia; Genentech; Horizon Pharma; Incyte; Ipsen; Janssen; LEO Pharma; Medtronic; Meyer; MSD; Novartis; Novo Nordisk; Parexel; Pfizer; Pharmacyclics; Reata Pharmaceuticals; Roche; Sanofi; Sunovion; Synexus; Teva Pharmaceutical Industries Ltd; UCB Pharma; Vifor Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.